// App-Quantinova.ai

909 : Identifications of Highly Aggressive Phenotype with SPI1 Overexpression in Pediatric T Cell Acute Lymphoblastic Leukemia/Lymphoma

Researchers

Presenter

  • Masafumi Seki

Principal Investigators

  • Kenichi Yoshida

  • Hiroko Tanaka

  • Masatoshi Takagi

  • Atsushi Iwama

  • Kentaro Oki

  • Motohiro Kato

  • Katsuyoshi Koh

  • Ryoji Hanada

  • Hiroshi Moritake

  • Ryoji Kobayashi

  • Takao Deguchi

  • Tomoya Isobe

  • Yoshiko Hashii

  • Toshihiko Imamura

  • Atsushi Sato

  • Keizo Horibe

  • Nobutaka Kiyokawa

  • Atsushi Manabe

  • Akira Ohara

  • Masashi Sanada

  • Yasuhide Hayashi

  • Hiroyuki Mano

  • Hiroo Ueno

  • Satoru Miyano

  • Akira Oka

  • Seishi Ogawa

  • Junko Takita

  • Hiromichi Suzuki

  • Yusuke Shiozawa

  • Keisuke Kataoka

  • Yoichi Fujii

  • Yuichi Shiraishi

  • Kenichi Chiba

Medical Centers

  • Department of Human Genetics, Graduate School of Medicine- University of Tokyo, Japan

  • Department of Cellular and Molecular Medicine, Chiba University, Chiba, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

  • Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  • Department of Pediatrics, Hiroshima University Graduate School of Bomedical Sciences, Hiroshima, Japan

  • Department of Cellular Signaling, Tokyo University Graduate School of Medicine, Tokyo, Japan

  • Department of Hematology and Oncology, Shizuoka Childrens Hospital, Shizuoka, Japan

  • Laboratory of DNA information Analysis & Laboratory of Sequence Analysis, Human Genome Center, The University of Tokyo, Tokyo, Japan

  • Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  • Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan

  • Department of Biostatistics, The University of Tokyo, Tokyo, Japan

  • Division of Pediatrics, University of Miyazaki, Miyazaki, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Clinical Rsch Cntr, National Hosp Organization, Nagoya Med Cntr, Nagoya, Japan

  • Department of Pediatrics, St. Lukes International Hospital, Tokyo, Japan

  • Human Genome Center Institute of Medical Science University of Tokyo, Tokyo, Japan

  • Sapporo Hokuyu Hospital, Sapporo, Japan

  • Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Department of Biostatistics, The University of Tokyo, Tokyo, Japan

  • Laboratory of DNA Information Analysis, Human Genome Center, The University of Tokyo, Tokyo, Japan

  • Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Colony stimulating factor 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim